Purdue Asks Federal Circuit To Rehear OxyContin Patent Case

Law360, New York (July 25, 2005, 12:00 AM EDT) -- Purdue Pharma has asked the U.S. Court of Appeals for the Federal Circuit to review its decision last month to uphold a lower court’s devastating determination that three patents for the blockbuster painkiller OxyContin are unenforceable due to inequitable conduct before the U.S. Patent and Trademark Office.

The petition is seeking an “en banc” rehearing by the full panel of judges of the court following a three-judge panel’s unanimous affirmance last month of a decision by the U.S. District Court for the Southern District of New...
To view the full article, register now.